Search Result "Glutamatergic abnormalities"
Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 10 Year: 2013 Page: 1898-1922
Author(s): Gianluca Serafini,Maurizio Pompili,Marco Innamorati,Yogesh Dwivedi,Goutam Brahmachari,Paolo Girardi
Zinc in the Glutamatergic Theory of Depression
Journal: Current Neuropharmacology
Volume: 13 Issue: 4 Year: 2015 Page: 505-513
Author(s): Katarzyna Mlyniec
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 7 Year: 2020 Page: 554-584
Author(s): Domenico De Berardis,Carmine Tomasetti,Maurizio Pompili,Gianluca Serafini,Federica Vellante,Michele Fornaro,Alessandro Valchera,Giampaolo Perna,Umberto Volpe,Giovanni Martinotti,Silvia Fraticelli,Massimo Di Giannantonio,Yong-Ku Kim,Laura Orsolini
Assessing Glutamatergic Function and Dysfunction in Peripheral Tissues
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 9 Year: 2012 Page: 1310-1315
Author(s): L. Tremolizzo, G. Sala, C. P. Zoia, C. Ferrarese
Dysregulation of Glutamatergic Neurotransmission in Autism Spectrum Disorders
Ebook: Cellular and Molecular Biology of Autism Spectrum Disorders
Volume: 1 Year: 2010
Author(s): Anna Strunecka
Doi: 10.2174/978160805196011001010032
Ketamine and Glutamatergic Compounds: Exploring Biomarkers and Mechanisms Related to Rapid Antidepressant Action
Ebook: Frontiers in Drug Discovery
Volume: 2 Year: 2017
Author(s): Gislaine Z. Réus,Helena M. Abelaira,Gerard Sanacora,João Quevedo
Doi: 10.2174/9781681084732117020010
Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1595-1611
Author(s): Rodrigo Machado-Vieira, Giacomo Salvadore, Lobna A. Ibrahim, Nancy Diaz-Granados, Carlos A. Zarate Jr.
Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2009 Page: 157-170
Author(s): R. L. Blaylock, A. Strunecka
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 219-238
Author(s): Felice Iasevoli,Carmine Tomasetti,Elisabetta F. Buonaguro,Andrea de Bartolomeis
Glutamatergic Animal Models of Schizophrenia
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 12 Year: 2012 Page: 1593-1604
Author(s): Corina Bondi, Marguerite Matthews, Bita Moghaddam